Literature DB >> 2947109

[Clinical psychopharmacology of Ginkgo biloba extract].

D M Warburton.   

Abstract

From this general review of the pharmacological, psychopharmacological and clinical studies performed with Ginkgo biloba extract, the following conclusions can be drawn: the drug seems to be effective in patients with vascular disorders, in all types of dementia and even in patients suffering from cognitive disorders secondary to depression, because of its beneficial effects on mood. Of special concern are people who are just beginning to experience deterioration in their cognitive function. Ginkgo biloba extract might delay deterioration and enable these subject to maintain a normal life and escape institutionalization. In addition, Ginkgo biloba extract appears to be a safe drug, being well tolerated, even in doses many times higher than those usually recommended.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947109

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

1.  Ginkgo biloba extract and cognitive decline.

Authors:  D M Warburton
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.